for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

NantHealth Inc

NH.OQ

現在値

4.80USD

変化

0.00(0.00%)

出来高

158,744

本日のレンジ

4.78

 - 

5.22

52週レンジ

0.45

 - 

6.39

∙ 約20分前の相場を表示しています。

適時開示

Nanthealth Reports 2020 First Quarter Financial Results

May 7 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH REPORTS 2020 FIRST QUARTER FINANCIAL RESULTS.Q1 NON-GAAP LOSS PER SHARE $0.06 FROM CONTINUING OPERATIONS.Q1 REVENUE $18.2 MILLION.Q1 LOSS PER SHARE $0.08 FROM CONTINUING OPERATIONS.QTRLY SAAS REVENUE WAS $18.1 MILLION, UP 2%.

NantHealth Says Revenue Rose 6% To $24.2 Million

Feb 28 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH REPORTS 2019 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS.Q4 NON-GAAP LOSS PER SHARE $0.04 FROM CONTINUING OPERATIONS.Q4 REVENUE ROSE 6 PERCENT TO $24.2 MILLION.Q4 LOSS PER SHARE $0.11 FROM CONTINUING OPERATIONS.

Masimo Announces Select Preliminary Full-Year 2019 Financial Results And 2020 Guidance

Jan 14 (Reuters) - Masimo Corp <MASI.O>::MASIMO ANNOUNCES SELECT PRELIMINARY FULL-YEAR 2019 FINANCIAL RESULTS AND 2020 GUIDANCE.SEES FY 2020 REVENUE ABOUT $1.04 BILLION .SEES PRELIMINARY FULL-YEAR 2019 TOTAL REVENUE, INCLUDING ROYALTY AND OTHER REVENUE, OF APPROXIMATELY $934 TO $937 MILLION.SEES PRELIMINARY FULL-YEAR 2019 PRODUCT REVENUE OF APPROXIMATELY $933 TO $936 MILLION.SEES FULL YEAR 2020 NON-GAAP EARNINGS PER DILUTED SHARE $3.56.EXPECTS FULL-YEAR 2019 GAAP EARNINGS PER SHARE WILL EXCEED PREVIOUSLY ISSUED FINANCIAL GUIDANCE OF $3.37 PER DILUTED SHARE.EXPECTS FULL-YEAR 2019 NON-GAAP EARNINGS PER SHARE WILL EXCEED PREVIOUSLY ISSUED FINANCIAL GUIDANCE OF $3.18 PER DILUTED SHARE.EXPECTS AGREEMENT TO ACQUIRE CONNECTED CARE ASSETS FROM NANTHEALTH TO CONTRIBUTE ABOUT 1 PERCENT POINT TO ITS FY 2020 REVENUE GUIDANCE GROWTH RATE.COMPANY EXPECTS TRANSACTION WITH NANTHEALTH TO BE SLIGHTLY DILUTIVE TO NON-GAAP EARNINGS PER SHARE IN 2020.EXPECTS TRANSACTION WITH NANTHEALTH TO BE ACCRETIVE TO NON-GAAP EARNINGS PER SHARE BEGINNING IN 2021.SEES FY 2020 GAAP EARNINGS PER DILUTED SHARE $3.64.FY2019 EARNINGS PER SHARE VIEW $3.18, REVENUE VIEW $933.5 MILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $3.56, REVENUE VIEW $1.02 BILLION -- REFINITIV IBES DATA.

Masimo Corp To Acquire Connected Care Business From Nanthealth For $47.25 Mln

Jan 14 (Reuters) - NantHealth Inc <NH.O>::MASIMO TO ACQUIRE CONNECTED CARE BUSINESS FROM NANTHEALTH.MASIMO CORP - DEAL FOR A $47.25 MILLION UPFRONT CASH PAYMENT.MASIMO CORP - EXPECTS TO FUND ACQUISITION WITH EXISTING CASH ON HAND.MASIMO CORP - ESTIMATED FINANCIAL IMPACT OF TRANSACTION IS INCLUDED IN MASIMO'S FULL-YEAR 2020 FINANCIAL GUIDANCE.

NantHealth Reports 2019 Third-Quarter Financial Results

Nov 7 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH REPORTS 2019 THIRD-QUARTER FINANCIAL RESULTS.Q3 NON-GAAP LOSS PER SHARE $0.07 FROM CONTINUING OPERATIONS.Q3 REVENUE $22.4 MILLION VERSUS $22.3 MILLION.Q3 LOSS PER SHARE $0.15 FROM CONTINUING OPERATIONS.

Nanthealth Q2 Revenue Rose 17% To $25.7 Mln

Aug 8 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH REPORTS 2019 SECOND-QUARTER FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.13 FROM CONTINUING OPERATIONS.Q2 REVENUE ROSE 17 PERCENT TO $25.7 MILLION.Q2 NET LOSS PER SHARE FROM CONTINUING OPERATIONS NON-GAAP $0.04.

Nanthealth Received Non Compliance Notice From Nasdaq

June 28 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH INC - ON JUNE 24 RECEIVED NOTICE FROM NASDAQ STOCK MARKET LLC STATING CO WAS NOT IN COMPLIANCE WITH NASDAQ MVPHS RULE.NANTHEALTH INC - NOTICE HAS NO IMMEDIATE EFFECT ON NASDAQ LISTING OR TRADING OF COMPANY'S COMMON STOCK.

Nanthealth Reports Q1 Loss Per Share $0.18 From Continuing Operations

May 9 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH REPORTS 2019 FIRST-QUARTER FINANCIAL RESULTS.Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.10 FROM CONTINUING OPERATIONS.Q1 LOSS PER SHARE $0.18 FROM CONTINUING OPERATIONS.Q1 REVENUE $23.7 MILLION VERSUS $22.3 MILLION.

Nanthealth Q4 Loss Per Share $0.45 From Continuing Operations

March 28 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH REPORTS 2018 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS.Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.08 FROM CONTINUING OPERATIONS.Q4 LOSS PER SHARE $0.45 FROM CONTINUING OPERATIONS.Q4 REVENUE $22.9 MILLION VERSUS $22.3 MILLION.SAAS REVENUE OF $17.3 MILLION IN Q4, UP 9% FROM Q3.

NantHealth Reports 2018 Third-Quarter Financial Results

Nov 15 (Reuters) - NantHealth Inc <NH.O>::NANTHEALTH REPORTS 2018 THIRD-QUARTER FINANCIAL RESULTS.Q3 REVENUE $22.3 MILLION.Q3 ADJUSTED NON-GAAP LOSS PER SHARE $0.10 FROM CONTINUING OPERATIONS.QTRLY LOSS PER SHARE $0.89.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up